Baidu, Inc. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
Baidu, Inc. (BAIDF) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of CNY 263.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-03-17
- Baidu, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2018-12-31 was 430.00M CNY.
- Baidu, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2018-09-30 was 298.00M CNY.
CNY
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 263.00M CNY 20-F · filed 2026-03-17 | ||||
| 2024-12-31 | 292.00M CNY 20-F · filed 2026-03-17 | ||||
| 2023-12-31 | 753.00M CNY 20-F · filed 2026-03-17 | ||||
| 2022-12-31 | 2.46B CNY 20-F · filed 2025-03-28 | ||||
| 2021-12-31 | 4.26B CNY 20-F · filed 2024-03-15 | ||||
| 2020-12-31 | 2.31B CNY 20-F · filed 2023-03-22 | 2.30B CNY 20-F · filed 2021-03-09 | |||
| 2019-12-31 | 778.00M CNY 20-F · filed 2022-03-28 | 455.00M CNY 20-F · filed 2021-03-09 | |||
| 2018-12-31 | 430.00M CNY derived: 20-F 12 month − 6-K 9 month · filed 2021-03-09 | 728.00M CNY derived: sum of 2 quarters · filed 2021-03-09 | 778.00M CNY 20-F · filed 2021-03-09 | ||
| 2018-09-30 | 298.00M CNY 6-K · filed 2018-11-07 | 348.00M CNY 6-K · filed 2018-11-07 |
USD
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|---|---|
| 2025-12-31 | $38.00M 20-F · filed 2026-03-17 | ||
| 2024-12-31 | $40.00M 20-F · filed 2025-03-28 | ||
| 2023-12-31 | $106.00M 20-F · filed 2024-03-15 | ||
| 2022-12-31 | $356.00M 20-F · filed 2023-03-22 | ||
| 2021-12-31 | $668.00M 20-F · filed 2022-03-28 | ||
| 2020-12-31 | $354.00M 20-F · filed 2021-03-09 | ||
| 2018-09-30 | $43.00M 6-K · filed 2018-11-07 | $51.00M 6-K · filed 2018-11-07 |